LMW heparin (anti-Xa) assays for clinical monitoring and pharmacokinetic studies on the automated coagulation laboratory (ACL)
- 1 May 1992
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 66 (4) , 287-298
- https://doi.org/10.1016/0049-3848(92)90279-j
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Development and characterization of an automated assay of effective heparin activity in plasma.Clinical Chemistry, 1987
- Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4Biochemical Journal, 1984
- Newer Avenues in the Monitoring of Antithrombotic Therapy: The Role of AutomationSeminars in Thrombosis and Hemostasis, 1983
- Determination of the Biological Activity of Heparin by Use of a Chromogenic SubstrateThrombosis and Haemostasis, 1979
- Molecular weight dependence of the anticoagulant properties of heparin: Intravenous and subcutaneous administration of fractionated heparins to manThrombosis Research, 1979
- Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238)Thrombosis Research, 1978
- Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin IIIThrombosis Research, 1977
- Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtrationThrombosis Research, 1976
- The molecular-weight range of mucosal-heparin preparationsCarbohydrate Research, 1976
- Assay of heparin in plasma using a chromogenic substrate for activated factor XThrombosis Research, 1976